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Abstract—This extended abstract discusses our ongoing
research on augmenting the communication between an expert
and a layman using interactive visualizations. We are currently
designing an interactive table that assists patients and general
practitioners (GPs) to explore drug information using a camera
to recognize drug packages and a projector to visualize complex
drug information directly around these packages.
I. INTRODUCTION
An often stated solution to the challenges of healthcare
such as keeping healthcare affordable and accessible is
the ‘empowered patient’. In order to empower the patient,
information is a necessity. However, the data available is
not always medically validated and sometimes misleading
for the patient. Furthermore, it is not always straightforward
to communicate complex health information to patients.
We want to augment the communication between general
practitioners (GPs) and their patients using interactive
visualizations. Schneiderman, Plaisant and Hesse [1] discuss
several opportunities where visualizations can help to
improve healthcare. Based on requirements extracted from
several interviews with patients, we will design interactive
visualizations that assist GPs and patients to discuss complex
drug information. More specifically, we are designing an
interactive table that recognizes drug packages using computer
vision techniques and that visualizes drug interactions, adverse
drug reactions, intolerances and posology using a projector. A
specific novelty of what we propose is the focus on improving
the communication between an expert user (the GP) and a
layman (the patient) using projected interactive visualizations
with tangible objects in order to help patients gain insights
about their drug use. We make use of tabletop affordances
such as ‘co-location’, ‘multiple users’, ‘hands-on activities’
and ‘multiple modes of communication’[2].
II. RESEARCH QUESTIONS
In our research, we want to learn in general 1) how we
can improve the communication between an expert and a
layman using interactive visualizations and, more specifically
2) how we can leverage tabletop affordances using information
visualization techniques to augment adverse drug events
awareness amongst patients. It should also be researched how
medically validated data should be visualized in order to
expose insights in the patient’s health status.
III. RESOURCES AND METHODS
In our earlier research [3], [4] we intensively worked
with GPs to design and evaluate designs that augment GPs’
workflow. Furthermore, a collaborative funded project with
industry partners enables us to get access to real data, real
patients and real GPs - though our earlier experience makes
it clear that availability of GPs for evaluation studies is
always an issue. Finally, this research is situated in the
augment group of the KU Leuven1 which provides us with the
necessary expertise on human augmentation and information
visualization.
We follow a user centered design methodology, where
interviews with GPs and patients enable us to ground our
research in real usage context. This means that users need
to be able to touch the buttons of a working, realistic
proof-of-concept and see how the visualizations actually work.
With the help of proven methods such as structured interviews,
think aloud user tests, task analysis and user tracking, we
can update and enhance the prototypes in each iteration. In
order to prevent that usability issues would influence our
results, the usability of each prototype is measured with the
system usability scale (SUS). The final evaluations rely on
scenario-based evaluations [5].
IV. EXPECTED RESULTS
After the rapid prototyping process, we expect to have
a design which integrates our interactive visualizations and
which augments the discussion about drug use between a GP
and a patient. We thus hope to empower patients by raising
their understanding of drug usage and reactions between drugs.
In addition, thanks to using medically validated data, we hope
to prevent known adverse drug events.
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